Sino Biopharmaceutical Ltd - Operating Expenses

Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in HKD, Billions.

The item "Operating-Expenses" stands at 18.60 Billion Hong Kong Dollars for the trailing twelve months (TTM) period ending 06/30/2025.

Sino Biopharmaceutical Ltd's second quarter result of 5.37 Billion HKD for the item "Operating Expenses" represents no change compared to it's first quarter result.

Also, Sino Biopharmaceutical Ltd's second quarter result of 5.37 Billion HKD for the item "Operating Expenses" represents an increase of 22.29 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Sino Biopharmaceutical Ltd's second quarter result of 18.60 Billion HKD for the item "Operating Expenses" represents an increase of 5.55 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 25.15 percent compared to the value the year prior.
The 1 year change in percent is 25.15.
The 3 year change in percent is 6.97.
The 5 year change in percent is 40.31.
The 10 year change in percent is 200.95.

The Serie's long term average value is 10.15 Billion Hong Kong Dollars. It's latest available value, on 06/30/2025, is 83.32 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2011, to it's latest available value, on 06/30/2025, is +551.38%.
The Serie's change in percent from it's maximum value, on 09/30/2024, to it's latest available value, on 06/30/2025, is -1.68%.